Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04979416 · ClinicalTrials.gov registry record · NA
Video Messages and Vaccination Intention
A NA study of COVID-19 Vaccination, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 1,001
- Enrollment target
- 1
- Study location
NCT04979416 is a NA study of COVID-19 Vaccination that has completed, run by University of Southern California. The registered enrollment target is 1,001 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04979416, a NA study of COVID-19 Vaccination, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,001 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. The key endpoint is a question about the likelihood of getting vaccinated in the next 30 days.
Conditions Studied
Interventions
- BEHAVIORAL Video messages
Study Locations (1)
California
- USC - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,001 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2021-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04979416
The ClinicalTrials.gov registry entry for NCT04979416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,001 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Video messages is the first listed.
NCT04979416 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04979416 about?
NCT04979416 is a clinical study titled "Video Messages and Vaccination Intention". This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. T...
What is the current status of trial NCT04979416?
This trial is currently completed. It is a NA study. The enrollment target is 1,001 participants. The study started on 2021-07-21. Estimated completion is 2021-07-22.
What conditions does trial NCT04979416 study?
This clinical trial studies the following conditions: COVID-19 Vaccination.
What interventions are being tested in trial NCT04979416?
The interventions under investigation include: Video messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT04979416?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04979416 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.